Ginkgo Bioworks Inc. (DNA)
NYSE: DNA
· Real-Time Price · USD
9.14
0.61 (7.15%)
At close: Jun 24, 2025, 3:59 PM
9.39
2.74%
Pre-market: Jun 25, 2025, 06:14 AM EDT
7.15% (1D)
Bid | 9.33 |
Market Cap | 534.98M |
Revenue (ttm) | 237.42M |
Net Income (ttm) | -472.07M |
EPS (ttm) | -8.91 |
PE Ratio (ttm) | -1.03 |
Forward PE | -2.11 |
Analyst | Sell |
Ask | 9.4 |
Volume | 1,411,437 |
Avg. Volume (20D) | 1,215,491 |
Open | 8.60 |
Previous Close | 8.53 |
Day's Range | 8.60 - 9.27 |
52-Week Range | 5.00 - 16.85 |
Beta | 1.26 |
Analyst Forecast
According to 0 analyst ratings, the average rating for DNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Ginkgo Bioworks Inc. is scheduled to release its earnings on Aug 7, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+14.73%
Ginkgo Bioworks shares are trading higher after th...
Unlock content with
Pro Subscription
2 months ago
+11.23%
Shares of healthcare technology stocks are trading higher. Some stocks in the sector rose after the FDA stated plans to phase out animal testing requirements for monoclonal antibodies and other drugs.

1 week ago · accessnewswire.com
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. HaywardPresident and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO STONY BROOK, NY / ACCESS Newswire / June 17, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or...

3 weeks ago · accessnewswire.com
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effec...